JBTMarel Corp shares fell to a 52‑week low of $110.15 USD, just 1% above the prior low of $110.19. The price represents a 1‑year decline of 18.44% and a year‑to‑date loss of 26%.
In its second‑quarter results, the company reported adjusted earnings of $1.95 per share, below the consensus estimate of $2.02, and revenue of $981 million, shy of the $988.43 million forecast. Despite the miss, JBTMarel said it recorded over $1 billion in orders for the third consecutive quarter and kept its full‑year outlook unchanged.
Analyst response was mixed but generally supportive. Barclays initiated coverage with an overweight rating, citing the quality of the JBT‑Marel merger and an attractive risk/reward profile despite recent margin concerns. KeyBanc also started coverage overweight, highlighting potential value creation from integrating the JBT and Marel platforms. Jeffrey Hammond, an analyst at KeyBanc, noted that the market may be underestimating the company’s execution abilities given the merger’s complexity.
